PM

Peter Moldt

Senior Partner at Novo Ventures

San Francisco, California

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Investments

INBRACE

Series C

Total Funding: $150M

Bolt Biotherapeutics

Series B

Total Funding: $150M

ViewPoint Therapeutics

Series B

Total Funding: $35M

Arch Oncology

Series A

Total Funding: $86M